Skip to main content
OpenTrials
Completed

NCT Number: NCT01639586

Comparison for the Patient With Alzheimer Disease the Impact of Three Different Groups of Patient Care

One of the interests of the Alzheimer Plan 2008-2010 is to provide increase support to helping families. It's also of major to involve the patient in the most active treatment possible, encouraging social inter relationship as well as cognitive and behavioural stimulation activities.

In the frame of non drug related approaches to Alzheimer disease (AD), several research projects and actions have already been conducted, but no specific study concerning the efficiency of different types of respite care structures have been conducted so far in France. The present project concerns the thematic of the frame "Development and diversification of respite care structures".

A platform is defined in the Alzheimer Plan as a "diversified range of despite structures according to patients' needs and informal caregivers' expectations" providing several objectives:

Two objectives targeting the informal caregivers:

* offer spare time or tutored * inform, support and accompany

Two objectives targeting the patients:

* encourage maintain of the patient social life and relationships and work together towards his/her psychological and emotional well-being * contribute to improve functional cognitive and sensory capacities

The study COMPARSE suggests to compare for the patient - informal caregiver couple, the impact of three different groups of patient care on health profit; resit platform (P), the day care group (D), the control group without access to a respite structure (C).

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Le Duff

Nice, 06000, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patient affect by Alzheimer disease or related pathology
  • patient with an informal caregiver
  • patient not using any respite structure
  • signed informed consent (patient and informal caregiver)
  • affiliate to social security

Exclusion criteria

  • patient without informal caregiver
  • patient include in another clinical protocol

Exclusion criteria

-

Treatment and study plan

respite platform

Behavioral

Impact of the respite platform patient care on health profit

Day care

Behavioral

Impact of the day care on health profit of patient

No access to a respite structure

Behavioral

Control group without access to a respite structure

Primary outcomes

  1. Analysis of the perceived and diagnosed health evolution of the patient

    Time frame: at baseline, one month and nine month

    Realize neuropsychological evaluation and satisfaction degree evaluation of the patient and the informal caregiver to compare different types of respite care structures

Secondary outcomes

  1. Efficacity of the different structures

    Time frame: at baseline, one month and nine month

    Assess autonomy level of patient Realize sociological qualitative analysis and economic evaluation by comparing differents structures

Sponsors and collaborators

Lead sponsor

Department of Clinical Research and Innovation

Other

Registry information

Official study title

Comparaison du Service Rendu à la Personne Atteinte d'Une Maladie d'Alzheimer et de l'Aidant Par Trois Types de Prises en Charge (Plateforme, Accueil de Jour et Groupe contrôle

Acronym: COMPARSE

Important dates

Study start
2011
Primary completion
2012
Study completion
2013
First posted
Jul 12, 2012
Registry last updated
Mar 22, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.